CSI Market
Sign In | Register

Universal Biosensors Inc (UBI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access UBI quarterly Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Universal Biosensors Inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Operating Activities
Income-9.39
Depreciation & amortization0.53
Amortization of Other Assets0.05
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Finite-lived0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.80
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.07
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized-0.01
Noncash Lease Expense-0.60
Increase Decrease In Contract With Customer Liability-0.04
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-0.73
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.62
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.70
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.50
Discontinued operations0.00
Net Cash flow from Operating Activities-8.11
Investing Activities
Capital Expenditures-0.27
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Government Grant Reimbursements For Property And Equipment-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.27
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.60
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.31
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net7.61
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Proceeds From Issuance Of Common Stock Net12.02
Finance Lease Principal Payments-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.32
Effect of exchange rate on cash flow-0.05
Discontinued operations0.00
Free Cash Flow-8.39
Total Cash Flow-1.07
4 historic quarters locked

Sign in to unlock the full Universal Biosensors Inc cash flow history.

Sign In Create Free Account

About Universal Biosensors Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-25-005171

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License